Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 58 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4499 Medical Dr
Ste 102
San Antonio, TX 78229Phone+1 210-614-0402Fax+1 210-614-2838- Is this information wrong?
Summary
- Dr. Mark Lee, MD is a board certified dermatologist in San Antonio, Texas. He is currently licensed to practice medicine in Texas, Arizona, and California. He is affiliated with Methodist Hospital, University Medical Center at Brackenridge, and St. David's Medical Center.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumResidency, Dermatology, 1991 - 1994
Valleywise HealthInternship, Transitional Year, 1987 - 1988
George Washington University School of Medicine and Health SciencesClass of 1987
Certifications & Licensure
AZ State Medical License 1996 - Present
CA State Medical License 1990 - Present
TX State Medical License 1995 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
- A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
- A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) Start of enrollment: 2015 Nov 16
- Join now to see all
Publications & Presentations
PubMed
- Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.Leon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, Michael Bukhalo, Alim R Devani, Zoe D Draelos, Janet DuBois, Melinda J Gooderham, Steven E Kempers, Edward Lain, ...> ;The British Journal of Dermatology. 2023 Sep 15
- 3 citationsOral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study.Pablo A Jimenez, Howard L Sofen, Robert Bissonnette, Mark Lee, Joseph Fowler, David J Zammit, Yusong Chen, Niranjan Rao, Louis Denis, Sandeep Gupta> ;Journal of the American Academy of Dermatology. 2023 Aug 1
- 14 citationsA Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis.Robert Bissonnette, Robert S Call, Tooraj Raoof, Zhaoyin Zhu, Swamy Yeleswaram, Xiaohua Gong, Mark Lee> ;American Journal of Clinical Dermatology. 2022 May 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Methodist HospitalSan Antonio, Texas
St. David's Medical CenterAustin, Texas
University Medical Center at BrackenridgeAustin, Texas- Doctors Hospital of LaredoLaredo, Texas
